Dual Targeting of Syndecan-1 and Glucose Transporter-1 With a Novel Lipid-Based Delivery System Enhances Therapeutic Efficacy and Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma
Gastroenterology. 2024 Sep 14:S0016-5085(24)05461-1.
doi: 10.1053/j.gastro.2024.09.009.
Online ahead of print.
1 Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Sciences, Jacksonville, Florida.
2 Department of Biochemistry and Molecular Biology; Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine and Sciences, Jacksonville, Florida.
3 Department of Biochemistry and Molecular Biology; Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine and Sciences, Jacksonville, Florida. Electronic address: mukhopadhyay.debabrata@mayo.edu.